Back to search

Germany· DE-A57-008857e686b0c4a5

Arnica E Floribus W 5%

A medicinal product containing arnica montana e floribus w 5% (hab, vs. 12g mit nativem olivenöl), registered in Germany by Wala Heilmittel Gmbh.

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedArnica E Floribus W 5%ATC—REGISTER NO.DE-A57-008857e686b0c4…PACKS LISTED0CHECKEDSeptember 30, 2026

The record

At a glance

EMA Article 57 (European Union)
Active substance
Arnica Montana E Floribus W 5% (Hab, Vs. 12g Mit Nativem Olivenöl)
Manufacturer
Wala Heilmittel Gmbh
Country
Germany (DE)
ATC code
—
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/af1f18e6-faac-4433-a1fe-f8eaa4aff8db
GET /v1/drugs/af1f18e6-faac-4433-a1fe-f8eaa4aff8db?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Cutaneous Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Arnica Montana E Floribus W 5% (Hab, Vs. 12g Mit Nativem Olivenöl)",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about arnica montana e floribus w 5% (hab, vs. 12g mit nativem olivenöl).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.